Ignite Creation Date:
2025-12-24 @ 11:52 AM
Ignite Modification Date:
2026-01-02 @ 12:57 PM
Study NCT ID:
NCT02843061
Status:
COMPLETED
Last Update Posted:
2019-09-12
First Post:
2016-07-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of Rituximab and NK Immunotherapy for B Lymphoma
Sponsor:
Fuda Cancer Hospital, Guangzhou
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2017-07-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-07-01
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-21
First Submit QC Date:
None
Study First Post Date:
2016-07-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-10
Last Update Post Date:
2019-09-12
Last Update Post Date Type:
ACTUAL